Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease

被引:74
作者
D'Andrea, MR [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
关键词
Alzheimer's disease; apoptosis; autoimmune disease (autoimmunity); blood-brain barrier; immunoglobulin; neurodegeneration;
D O I
10.1016/S0006-8993(03)02881-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The catastrophic loss of cerebral neurons in Alzheimer's disease (AD) is not fully understood. Since serum proteins are known to extravasate into the brain parenchyma in AD due to blood-brain barrier (BBB) dysfunction, this study was designed to explore the possibility that neuronal cell death may be the consequence of the anomalous presence of serum proteins in the brain. As compared to age-matched, non-demented 'control' brain tissues, highly significant increases of immunoglobulins (Igs) were detected in parenchyma, which were associated with vessels in the AD brain tissues. Also, there were dramatic increases of (+)Ig-neurons in areas with greater parenchymal Ig reactivity. The Ig labeling extended throughout the cell, which showed neurodegenerative apoptotic features that were not observed in (-)Ig-neurons. Thus, the presence of (+)Ig-neurons in AD brains implies a critical link between the faulty BBB and neuronal death through an autoimmune mechanism. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:19 / 30
页数:12
相关论文
共 35 条
  • [1] Neural apoptosis
    Bredesen, DE
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (06) : 839 - 851
  • [2] ANTIBODIES TO CHOLINERGIC NEURONS IN ALZHEIMERS-DISEASE
    CHAPMAN, J
    BACHAR, O
    KORCZYN, AD
    WERTMAN, E
    MICHAELSON, DM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (02) : 479 - 485
  • [3] Claudio L, 1996, ACTA NEUROPATHOL, V91, P6
  • [4] Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease
    D'Andrea, MR
    Nagele, RG
    Wang, HY
    Peterson, PA
    Lee, DHS
    [J]. HISTOPATHOLOGY, 2001, 38 (02) : 120 - 134
  • [5] The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations
    D'Andrea, MR
    Reiser, PA
    Polkovitch, DA
    Gumula, NA
    Branchide, B
    Hertzog, BM
    Schmidheiser, D
    Belkowski, S
    Gastard, MC
    Andrade-Gordon, P
    [J]. NEUROSCIENCE LETTERS, 2003, 342 (1-2) : 114 - 118
  • [6] Consistent immunohistochemical detection of intracellular β-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex
    D'Andrea, MR
    Nagele, RG
    Wang, HY
    Lee, DHS
    [J]. NEUROSCIENCE LETTERS, 2002, 333 (03) : 163 - 166
  • [7] Targeting intracellular Aβ42 for Alzheimer's disease drug discovery
    D'Andrea, MR
    Lee, DHS
    Wang, HY
    Nagele, RG
    [J]. DRUG DEVELOPMENT RESEARCH, 2002, 56 (02) : 194 - 200
  • [8] MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease
    D'Andrea, MR
    Nagele, RG
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2002, 77 (02) : 95 - 103
  • [9] Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease
    D'Andrea, MR
    Reiser, PA
    Gumula, NA
    Hertzog, BM
    Andrade-Gordon, P
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2001, 76 (02) : 97 - 106
  • [10] DANGELO C, 1986, IMMUNOL IMMUNOFARMAC, V6, P8